Torigen Pharmaceuticals Founder Recognized as a ‘Domer Dozen’
Share Article
Ashley Kalinauskas chosen by the YoungND Board at the University of Notre Dame as an extraordinary young alum for her work in helping pets fight cancer and live healthy lives FARMINGTON, Conn. (PRWEB) April 28, 2021
Torigen Pharmaceuticals Inc., a commercial-stage companion animal immuno-oncology company, today announced that founder and CEO, Ashley Kalinauskas, was recently named to the Domer Dozen by the YoungND Board of the University of Notre Dame Alumni Association for her work in developing an affordable cancer treatment for veterinary patients.
Now in its second year, the Domer Dozen celebrates and highlights young alumni that have shown extraordinary dedication to the four tenents of the Alumni Association’s mission statement faith, service, learning, or work.
SOUTH BEND â The University of Notre Dame is still planning for an in-person commencement this spring, the Rev. John Jenkins, president of the university, announced Wednesday.
The in-person ceremonies celebrating the Class of 2021 will take place the weekend of May 21 to May 23 with a limited number of family and guests invited, subject to public health guidance available closer to the commencement weekend. The university will make celebrations available online to family and friends unable to attend in person.
âWe believe at this time that it will be possible to safely host these events â with some modifications, of course â with and for our graduates, who will have been on campus all semester and therefore subject to regular surveillance testing and the many other public health protocols that are in place,â Jenkins wrote in a letter to the Notre Dame community.